Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Metabolic syndrome].

V Boursier1

  • 1Service de Médecine Vasculaire, Hôpital Saint-Joseph, Paris. vboursier@hopital-saint-joseph.org

Journal Des Maladies Vasculaires
|November 8, 2006
PubMed
Summary
This summary is machine-generated.

Metabolic syndrome, a cluster of conditions increasing cardiovascular risk, affects people globally. Management focuses on weight reduction, physical activity, and medications for associated risk factors like high blood pressure.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Improving blood pressure control after a stroke: The place of therapeutic education in the acute phase].

Journal de medecine vasculaire·2019
Same author

Compression therapy in 100 consecutive patients with venous leg ulcers.

Journal des maladies vasculaires·2013
Same author

[Interest of cutaneous resection after reduction of volume by decongestive physiotherapy in huge primary lymphedema of lower limb].

Journal des maladies vasculaires·2005
Same author

[Comparative analysis of lymphoscintigraphy between lipedema and lower limb lymphedema].

Journal des maladies vasculaires·2005
Same author

[Limb lymphedema as a first manifestation of primary intestinal lymphangiectasia (Waldmann's disease)].

Journal des maladies vasculaires·2004
Same author

[Quantitative evaluation and qualitative results of surgical lymphovenous anastomosis in lower limb lymphedema].

Journal des maladies vasculaires·2003
Same journal

Renal function and venous thromboembolic diseases.

Journal des maladies vasculaires·2016
Same journal

[Ankle-brachial index screening for peripheral artery disease in high cardiovascular risk patients. Prospective observational study of 370 asymptomatic patients at high cardiovascular risk].

Journal des maladies vasculaires·2016
Same journal

[Erratum to "When to worry about before a vascular chronic leg ulcer?" [J. Mal. Vasc. 41 (2016) 307-314]].

Journal des maladies vasculaires·2016
Same journal

[Deep venous thrombosis of the upper limb in a violin player: The "bow syndrome"].

Journal des maladies vasculaires·2016
Same journal

[Economic consequences of biological monitoring and medical complications of injectable anticoagulants in France].

Journal des maladies vasculaires·2016
Same journal

[Vitamin K antagonist, direct oral anticoagulants: Where is the truth?]

Journal des maladies vasculaires·2016
See all related articles

Area of Science:

  • Cardiology
  • Endocrinology
  • Public Health

Background:

  • Metabolic syndrome is a significant public health concern characterized by a cluster of risk factors.
  • These factors include insulin resistance, hyperglycemia, overweight, hypertriglyceridemia, and altered LDL-cholesterol levels, all contributing to increased cardiovascular risk.
  • Multiple definitions exist, with the World Health Organization (WHO) and National Cholesterol Education Program (NCEP-ATPIII) being widely adopted.

Purpose of the Study:

  • To review the definitions, prevalence, underlying mechanisms, and management strategies for metabolic syndrome.
  • To highlight the association of metabolic syndrome with increased cardiovascular and type II diabetes risks.
  • To identify areas requiring further research, particularly regarding underlying mechanisms and comparative risk assessment.

Related Experiment Videos

Main Methods:

  • Review of proposed definitions of metabolic syndrome from 1998 to 2005.
  • Analysis of prevalence data across different geographic regions, age groups, and genders.
  • Discussion of the role of visceral adipose tissue and current management approaches.

Main Results:

  • Prevalence varies geographically and by definition, generally higher in the US than Europe and increasing with age.
  • Metabolic syndrome is linked to elevated cardiovascular and type II diabetes risks, though comparative risk versus individual factors needs more evidence.
  • Visceral adipose tissue is implicated in the syndrome's pathophysiology, particularly in relation to obesity and insulin resistance.

Conclusions:

  • Metabolic syndrome is a critical public health issue associated with significant cardiovascular and diabetes risks.
  • Effective management involves lifestyle modifications such as weight reduction and physical activity, potentially supplemented by pharmacotherapy.
  • Further research is needed to fully elucidate the mechanisms and precisely quantify the risks associated with metabolic syndrome.